Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 5A on p. 1305, the same xenograft tumor image had been selected for a pair of the GFP/U2‐OS experiments, where the images from discretely performed experiments were intended to have been shown. Furthermore, upon performing an independent analysis of the data in the Editorial Office, it was noted that the data selected for the 'SaO2/GFP/24 h' and 'SaO2/HMGN2/48 h' experiments in Fig. 4A, also on p. 1305, were strikingly similar, such that the same data had apparently been chosen to show the results of differently performed experiments. After having inspected the figures, the authors realized that one of the n=3 experimental results had inadvertently been omitted from Fig. 5A, and the data shown to represent the 'SaO2/GFP/24 h' experiment had been chosen incorrectly. The revised and corrected versions of Figs. 4 and 5 are shown on the next page (also note that erroneously written labels have been corrected in Fig. 5C: "Tumor volume" has been replaced by "Tumor weight"). Note that the errors made in terms of the assembly of the data in these figures did not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for granting them this opportunity to publish a Corrigendum, and apologize to boh the Editor and the readership for any inconvenience caused. [Oncology Reports 33: 1300‐1306, 2015; DOI: 10.3892/or.2014.3689]

Correction: Yang L, et al., “Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity”, Cancer Biol Ther 2014; 15:61–8.

Erratum: Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Correction To: Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cells: the Effect of Combining RNA Interference with Tyrosine Kinase Inhibitors or Cetuximab

Correction To: EBV-miR-BART8-3p Induces Epithelial-Mesenchymal Transition and Promotes Metastasis of Nasopharyngeal Carcinoma Cells Through Activating NF-κB and Erk1/2 Pathways

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction for Lin Et Al., “Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Promotes the Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Via Metastatic Tumor Antigen 1 and Mechanistic Target of Rapamycin Signaling Induction”

Corrigendum to ‘silencing KIF18B Enhances Radiosensitivity: Identification of a Promising Therapeutic Target in Sarcoma’ [ebiomedicine 61 (2020) 103,056]

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Correction: Corrigendum: Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum

[Corrigendum] Nucleosome‐binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‐OS osteosarcoma cell lines

Correction: YAP Suppresses Lung Squamous Cell Carcinoma Progression Via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation

[Corrigendum] Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans

Targeting The Epidermal Growth Factor Receptor In Non-Small Cell Lung Cancer Cells: The Effect Of Combining Rna Interference With Tyrosine Kinase Inhibitors Or Cetuximab (Vol 10, 28, 2012)

Author Correction: Synergistic Suppression of Human Breast Cancer Cells by Combination of Plumbagin and Zoledronic Acid in Vitro

Correction: Author Correction: Menin enhances c-Myc-mediated transcription to promote cancer progression

[Corrigendum] HIF‑1α Promotes ZEB1 Expression and EMT in a Human Bladder Cancer Lung Metastasis Animal Model

[Corrigendum] Identification of Lncrna EGOT As a Tumor Suppressor in Renal Cell Carcinoma

Correction To: PHF8 Upregulation Contributes to Autophagic Degradation of E-cadherin, Epithelial-Mesenchymal Transition and Metastasis in Hepatocellular Carcinoma

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)